Integra Lifesciences Holdings Corp balance sheet
At the end of fiscal 2025, Integra Lifesciences Holdings Corp had total assets of $3.60bn, total liabilities of $2.56bn and shareholders' equity of $1.04bn. It held $235m in cash against $1.73bn of debt: net debt of $1.49bn.
Balance sheet
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 72 | 129 | 101 | 97 | 121 | 72 | 48 | 102 | 175 | 139 | 199 | 470 | 513 | 457 | 276 | 246 | 235 | 252 |
| Receivables | 103 | 106 | 118 | 115 | 118 | 110 | 132 | 148 | 252 | 266 | 275 | 226 | 232 | 263 | 259 | 272 | 279 | 249 |
| Inventory | 140 | 147 | 171 | 172 | 207 | 189 | 211 | 217 | 296 | 280 | 316 | 310 | 317 | 325 | 390 | 429 | 493 | 464 |
| Total current assets | 365 | 445 | 452 | 453 | 521 | 529 | 438 | 495 | 822 | 775 | 858 | 1,237 | 1,154 | 1,161 | 1,058 | 1,082 | 1,160 | 1,190 |
| Goodwill | 262 | 262 | 293 | 294 | 250 | 363 | 512 | 511 | 938 | 926 | 954 | 932 | 1,013 | 1,039 | 1,055 | 1,097 | 615 | 608 |
| Total assets | 940 | 1,019 | 1,144 | 1,164 | 1,192 | 1,587 | 1,774 | 1,808 | 3,211 | 3,108 | 3,303 | 3,615 | 3,782 | 3,890 | 3,782 | 4,037 | 3,602 | 3,508 |
| Deferred revenue (current) | 4 | 4 | 5 | 4 | 4 | 5 | 6 | 7 | 11 | 4 | 5 | 5 | 5 | 7 | 9 | 10 | 11 | 12 |
| Total current liabilities | 157 | 202 | 102 | 107 | 119 | 126 | 139 | 124 | 349 | 263 | 331 | 401 | 340 | 321 | 307 | 922 | 456 | 329 |
| Long-term debt | — | — | — | — | — | — | — | — | — | 900 | 878 | 878 | 844 | 775 | 775 | 760 | 727 | 698 |
| Total debt | 237 | 155 | 353 | 322 | 205 | 413 | 482 | 665 | 1,781 | 1,211 | 1,199 | 933 | 844 | 775 | 826 | 1,661 | 1,730 | 1,697 |
| Total liabilities | 495 | 519 | 651 | 646 | 526 | 883 | 1,023 | 968 | 2,249 | 1,732 | 1,887 | 2,100 | 2,098 | 2,085 | 2,194 | 2,492 | 2,559 | 2,441 |
| Shareholders' equity | 445 | 500 | 493 | 518 | 666 | 704 | 751 | 840 | 962 | 1,376 | 1,417 | 1,515 | 1,685 | 1,804 | 1,588 | 1,545 | 1,043 | 1,067 |
| Net debt (negative = net cash) | 165 | 26 | 252 | 225 | 85 | 341 | 434 | 563 | 1,606 | 1,072 | 1,000 | 463 | 330 | 318 | 549 | 1,415 | 1,495 | 1,445 |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 272 | 252 | 285 | 262 | 279 | 264 | 267 | 249 |
| Inventory | 429 | 445 | 465 | 489 | 493 | 495 | 492 | 464 |
| Total current assets | 1,082 | 1,107 | 1,143 | 1,144 | 1,160 | 1,172 | 1,191 | 1,190 |
| Goodwill | 1,097 | 1,105 | 616 | 615 | 615 | 613 | 611 | 608 |
| Total assets | 4,037 | 4,053 | 3,668 | 3,646 | 3,602 | 3,578 | 3,563 | 3,508 |
| Deferred revenue (current) | 10 | 11 | 11 | 11 | 11 | 12 | 12 | 12 |
| Total current liabilities | 922 | 918 | 930 | 364 | 456 | 347 | 331 | 329 |
| Long-term debt | 760 | 756 | 746 | 736 | 727 | 717 | 707 | 698 |
| Total debt | 760 | 756 | 746 | 736 | 727 | 717 | 707 | 698 |
| Total liabilities | 2,492 | 2,529 | 2,629 | 2,609 | 2,559 | 2,535 | 2,520 | 2,441 |
| Shareholders' equity | 1,545 | 1,524 | 1,039 | 1,038 | 1,043 | 1,042 | 1,043 | 1,067 |
Compare with peers
- Merit Medical Systems Inc balance sheet
- Penumbra Inc balance sheet
- Integer Holdings Corp balance sheet
- Haemonetics Corp balance sheet
- Stevanato Group S.p.a. balance sheet
Head to head: IART vs MMSIIART vs PENIART vs ITGR
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies